1. Home
  2. UGRO vs ENSC Comparison

UGRO vs ENSC Comparison

Compare UGRO & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UGRO
  • ENSC
  • Stock Information
  • Founded
  • UGRO 2014
  • ENSC 2003
  • Country
  • UGRO United States
  • ENSC United States
  • Employees
  • UGRO N/A
  • ENSC N/A
  • Industry
  • UGRO Industrial Specialties
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • UGRO Consumer Discretionary
  • ENSC Health Care
  • Exchange
  • UGRO Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • UGRO 8.8M
  • ENSC 7.9M
  • IPO Year
  • UGRO N/A
  • ENSC N/A
  • Fundamental
  • Price
  • UGRO $0.77
  • ENSC $6.22
  • Analyst Decision
  • UGRO Strong Buy
  • ENSC
  • Analyst Count
  • UGRO 2
  • ENSC 0
  • Target Price
  • UGRO $5.63
  • ENSC N/A
  • AVG Volume (30 Days)
  • UGRO 130.1K
  • ENSC 58.2K
  • Earning Date
  • UGRO 03-26-2025
  • ENSC 03-14-2025
  • Dividend Yield
  • UGRO N/A
  • ENSC N/A
  • EPS Growth
  • UGRO N/A
  • ENSC N/A
  • EPS
  • UGRO N/A
  • ENSC N/A
  • Revenue
  • UGRO $70,320,066.00
  • ENSC $4,421,404.00
  • Revenue This Year
  • UGRO $17.15
  • ENSC $89.78
  • Revenue Next Year
  • UGRO $21.76
  • ENSC N/A
  • P/E Ratio
  • UGRO N/A
  • ENSC N/A
  • Revenue Growth
  • UGRO 12.08
  • ENSC 40.41
  • 52 Week Low
  • UGRO $0.60
  • ENSC $2.12
  • 52 Week High
  • UGRO $2.84
  • ENSC $17.63
  • Technical
  • Relative Strength Index (RSI)
  • UGRO 38.00
  • ENSC 40.62
  • Support Level
  • UGRO $0.70
  • ENSC $5.55
  • Resistance Level
  • UGRO $1.12
  • ENSC $7.36
  • Average True Range (ATR)
  • UGRO 0.12
  • ENSC 0.67
  • MACD
  • UGRO 0.01
  • ENSC -0.13
  • Stochastic Oscillator
  • UGRO 32.56
  • ENSC 24.86

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: